ConductScience.org, home

Trial · NCT03107026

Outcomes14

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in Number of Binge Daysbaseline and 12 WeeksITTbinge days/weekLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Binge Eating Clinical Global Impression-Severity( BE-CGI-S )Scorebaseline and 12 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYPercent of Subjects With a 4-week Cessation From Binge Eatingup to 12 WeeksITTParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYChange From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Scorebaseline and 12 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Number of Binge Days Per Week at Weeks 1, 2, 3, 4, 6, 8, and 10baseline and up to 10 WeeksITTbinge days/weekLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Number of Binge Episodes Per Week at Weeks 1, 2, 3, 4, 6, 8, 10, and 12baseline and up to 12 WeeksITTbinge episodesLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Binge-eating Clinical Global Impression-Severity (BE-CGI-S) Score at Weeks 2, 4, 6, 8, and 10baseline and up to 10 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Score at Weeks 2, 4, 6, 8, and 10baseline and up to 10 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Subscale Scores (Obsessions and Compulsions) at Weeks 2, 4, 6, 8, 10, and 12baseline and up to 12 weeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Sheehan Disability Scale (SDS) Total Score and Subscale Scores (School/Work Disability, Social Life Disability, and Family Life Disability) at Weeks 6 and 12baseline and 6 Weeks and 12 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Week 12baseline and 12 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Hamilton Anxiety Rating Scale (HAM-A) Total Score at Week 12baseline and 12 WeeksITTunits on a scaleLEAST_SQUARES_MEAN
SECONDARYProportion of Binge Eating Responders Who Have ≥ 75% Reduction in the Number of Binge Eating Episodes From Baseline at Week 1212 WeeksITTParticipantsCOUNT_OF_PARTICIPANTS
SECONDARY
Change From Baseline in Eating Disorder Examination Questionnaire (EDE-Q) Modified Including EDE-Q7 Global Score and 3 Subscale Scores (Dietary Restraint, Shape/Weight Overvaluation, and Body Dissatisfaction) at Week 12
baseline and 2 WeeksITTunits on a scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03107026/outcomes